朝聚眼科(02219)拟于2026年8月28日审议中期业绩及分红方案

公告速递
Aug 13

朝聚眼科医疗控股有限公司(02219)8月13日公告,董事会已排期于2026年8月28日(星期五)召开会议,届时将审议及批准集团截至2026年6月30日止六个月的中期业绩并予以公布,同时考虑建议派发中期股息(如有)。

公告显示,董事会目前由11名董事组成,包括董事长兼执行董事张波洲,执行董事张小利、张俊峰及张光弟;非执行董事Richard Chen Mao、李甄及张丽;以及独立非执行董事何明光、郭红岩、李建滨和宝山。

本次公告日期为2026年8月13日。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10